A new plant for producing plastic pharmaceutical packaging has been set up in the Chinese city of Changzhou to help satisfy the high demand for Gerresheimer’s primary packaging in China in the future. “From now on, we will also have production facilities in China to meet the needs of our customers and partners,” says...
Big pharma is facing down critics worried that expiring patents, a lack of new blockbuster treatments, constrained healthcare budgets and squeezed drug prices would up-end its business model. The success of orphan drugs is one reason why. Sales of treatments for rare diseases - known as orphan drugs - are growing fast...
H+E has founded a new joint venture: H+E Pharma GmbH, located in Stuttgart - together with the well-established Austar Group in order to provide better and more efficient support for our customers. H+E Pharma’s business will concentrate on the development, engineering, production, and sales of systems and parts for...
